43 participants
PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-02
- Start Date:
- 2023-03-15
- Completion:
- 2027-07-01
Conditions
- Acute Myeloid Leukemia
Interventions
- DRUG
- BIOLOGICAL
No Results Yet